Review: Male systemic lupus erythematosus: a review of sex disparities in this disease

Lupus - Tập 19 Số 2 - Trang 119-129 - 2010
L-J. Lu1, DJ Wallace2, ML Ishimori2, RH Scofield3, MH Weisman2
1Cedars Sinai Medical Center, Los Angeles, California, USA, Ren Ji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
2Cedars Sinai Medical Center, Los Angeles, California, USA
3Oklahoma Medical Research Foundation, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, Oklahoma City VA Medical Center, Oklahoma City, Oklahoma

Tóm tắt

Although males with systemic lupus erythematosus (SLE) represent 4—22% of all SLE patients, it may not be appropriate that these cases should be subordinated to females with SLE in terms of most health-related issues. Over the past few decades, some distinctive features of male lupus have been observed with regard to genetic and environmental aspects of sex differences, clinical features, and outcome. In addition, recent insights into sex disparities in this disease have brought forth a few plausible and novel pathogenetic hypotheses. This review discusses these findings and sex disparities in SLE that appear to be especially noteworthy and pertinent to our understanding of male SLE. Lupus (2010) 19, 119—129.

Từ khóa


Tài liệu tham khảo

10.1016/j.autrev.2006.10.001

10.1093/embo-reports/kvf206

10.1177/014107680710000102

10.1097/00005792-198309000-00005

10.1002/art.1780260107

10.1097/00005792-198509000-00001

Sthoeger ZM, 1987, Clin Exp Rheumatol, 5, 233

10.1016/0049-0172(89)90061-9

Ward MM, 1990, J Rheumatol, 17, 220

10.1136/ard.51.9.1050

10.1177/0961203392001005041

10.1097/00005792-199303000-00005

10.1016/0049-0172(94)90094-9

10.1097/00005792-199605000-00002

Lo JT, 1999, J Microbiol Immunol Infect, 32, 173

10.1191/0961203302lu253oa

10.1191/0961203305lu2245oa

10.1002/art.22375

10.1002/art.1780210413

10.1002/art.23416

10.1002/art.1780241002

10.1002/art.1780250109

10.1016/S1550-8579(04)80006-8

Lahita RG, 1996, Int J Fertil Menopausal Stud, 41, 156

10.1002/art.22683

10.1191/0961203303lu469xx

10.1002/art.1780380914

10.1191/096120399678847605

10.1191/096120398678920479

Soto ME, 2004, Clin Exp Rheumatol, 22, 713

10.1191/0961203304lu482oa

Specker C., 1994, Z Rheumatol, 53, 339

10.1097/00124743-200208000-00020

10.1093/rheumatology/33.4.339

10.1093/qjmed/81.3.1031

Celermajer DS, 1984, Am J Dis Child, 138, 586

Fries JF, 1975, Major Probl Intern Med, 6, v

Rabbani MA, 2005, J Pak Med Assoc, 55, 165

Keskin G., 2000, Clin Exp Rheumatol, 18, 114

Aranow C., 2002, J Rheumatol, 29, 1674

10.1093/rheumatology/33.4.307

10.1002/art.22676

Lu LJ, 2008, Semin Arthritis Rheum

Centers for Disease Control and Prevention., CDC-funded science. Funding Number: U58/CCU422885 and U58/CCU522826-02

10.1001/jama.1981.03310340024021

10.1136/ard.48.6.447

Folomeev M., 1990, J Rheumatol, 17, 856

10.1002/art.1780380218

10.1191/096120398678919930

Kiss E., 1999, Clin Exp Rheumatol, 17, 171

Ippolito A., 2008, Clin Exp Rheumatol, 26, S72

10.1136/ard.61.12.1065

10.1097/00124743-200106000-00003

10.1016/0049-0172(91)90057-7

10.1002/art.1780301202

10.1097/00005792-198905000-00002

Reveille JD, 1990, Arthritis Rheum, 33, 37, 10.1002/art.1780330105

10.1097/00005792-197103000-00001

10.1002/art.1780210609

Gilliland WR, 2000, Clin Exp Rheumatol, 18, 107

10.1002/art.23701

10.1002/art.22660

10.1183/09031936.98.11010041

10.1097/RHU.0b013e3181778ce0

10.1177/0961203308090026

10.1016/j.rdc.2004.10.001

10.1097/00002281-199909000-00005

10.1016/S1567-5769(01)00046-7

10.1016/0090-1229(92)90086-4

10.1007/s100670050075

10.1006/jaut.1996.0121

10.1002/art.1780400505

10.1002/art.22510

10.1002/art.10365

10.1097/01.rhu.0000256169.05087.ad

Zandman-Goddard G., 2007, J Rheumatol, 34, 1938

10.1002/art.1780261215

Lahita RG, 1982, Am J Kidney Dis, 2, 206

10.1023/A:1015467912592

10.1002/art.1780371109

Chuang E., 2007, Acta Biomed, 78, 255

Peeva E., 2005, Immunol Lett, 101

10.1084/jem.147.6.1568

10.1111/j.1468-1331.2006.01214.x

10.1210/en.2004-1003

Lahita RG, 1987, J Rheumatol, 14, 154

10.1016/j.molimm.2004.05.014

Singh RP, 2008, Arthritis Rheum, 58, S839

10.1177/096120339700600802

10.1177/0961203306069353

10.7326/0003-4819-142-12_Part_1-200506210-00004

10.1056/NEJMoa050817

10.1084/jem.20070850

10.1002/art.21733

10.4049/jimmunol.177.4.2088

10.1038/sj.gene.6364447

10.1006/brbi.1993.1022

10.1126/science.1124978

10.1002/art.22916

10.1126/science.1124662

10.1001/jama.295.12.1428

10.1016/S0167-5699(98)01298-5

10.1186/ar118

10.1016/S0167-5699(98)01409-1

10.1007/s12016-007-8051-0

10.4049/jimmunol.179.9.6352

10.1002/eji.200637016

10.1007/s00439-005-0061-5

Han S., 2008, PLoS ONE, 3, e0001757, 10.1371/journal.pone.0001757

10.1002/art.1780120103

10.1177/0961203307085111

10.1191/096120398678919697

Maldonado MA, 1999, J Immunol, 162, 6322, 10.4049/jimmunol.162.11.6322

10.1177/096120339900800502

Thông tin
Thông tin xuất bản

Lupus

Tập 19 Số 2

119-129

Thông tin tác giả